Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New navigation links 'Check who can join' and 'Find Contact Information' were added to the page, improving quick access to enrollment and contact details. The release tag now shows 'Revision: v3.6.0' and the previous 'Revision: v3.5.5' tag has been removed.
    Difference
    0.4%
    Check dated 2026-06-13T17:51:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous revision label (v3.5.4) on the study history page, signaling a new version of the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-06T14:20:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.5.4, indicating a new version of the study record history. This update does not change the underlying study data or trial details.
    Difference
    0.1%
    Check dated 2026-05-15T23:59:24.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number updates from **v3.5.2** to **v3.5.3**, indicating a site release without changing the trial record text.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:59:34.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Added a new Study Status section to the version history to reflect the trial's current status across revisions. An entry from 2026-03-12 was removed.
    Difference
    0.3%
    Check dated 2026-04-10T08:58:58.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.